Suppr超能文献

EGCG3"Me 阻断了阿脲诱导的糖尿病肾病中不溶性泛素化蛋白聚集体的形成。

Blockade of the formation of insoluble ubiquitinated protein aggregates by EGCG3"Me in the alloxan-induced diabetic kidney.

机构信息

Key Laboratory of Ministry of Education for Tea Science, Hunan Agricultural University, Changsha, Hunan Province, China ; Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing, China.

出版信息

PLoS One. 2013 Sep 30;8(9):e75687. doi: 10.1371/journal.pone.0075687. eCollection 2013.

Abstract

BACKGROUND

Renal accumulation of reactive carbonyl compounds (RCCs) has been linked to the progression of diabetic nephropathy. We previously demonstrated that carbonyl stress induces the formation of amino-carbonyl cross-links and sharply increases the content of β-sheet-rich structures, which is the seed of insoluble aggregates formation, and tea catechin (-)-epigallocatechin 3-gallate (EGCG) can reverse this process in vitro and in vivo. In this study, methylated derivative (-)-epigallocatechin-3-O-(3-O-methyl)-gallate (EGCG3"Me) was hypothesized to neutralize carbonyl stress mediating the formation of insoluble ubiquitinated protein (IUP) aggregates, and reduce the early development of diabetic nephropathy.

METHODS AND RESULTS

Diabetes was induced in mice by intraperitoneally injecting alloxan monohydrate (200 mg/kg/d) twice and administering EGCG3"Me by gavage for 15 d. Reagent case and western blot results showed that, in diabetic kidneys, the carbonyl proteins in the serum increased; and in insoluble protein fraction, 4-hydroxynonenal-modified proteins, IUP aggregates and p62 accumulated; FT-IR study demonstrated that the lipid content, anti-parallel β-sheet structure and aggregates increased. EGCG3"Me treatment could effectively reverse this process, even better than the negative control treatment.

CONCLUSIONS

EGCG3"Me exhibiting anti-β-sheet-rich IUP aggregate properties, maybe represents a new strategy to impede the progression of diabetic nephropathy and other diabetic complications.

摘要

背景

活性羰基化合物(RCC)在肾内的蓄积与糖尿病肾病的进展有关。我们之前的研究表明,羰基应激会诱导氨基酸-羰基交联的形成,并显著增加富含β-折叠结构的含量,这是不溶性聚集物形成的种子,而茶儿茶素(-)-表没食子儿茶素-3-没食子酸酯(EGCG)可以在体外和体内逆转这一过程。在这项研究中,我们假设甲基化衍生物(-)-表没食子儿茶素-3-O-(3-O-甲基)-没食子酸酯(EGCG3"Me)可以中和羰基应激,从而抑制不溶性泛素化蛋白(IUP)聚集物的形成,并减少糖尿病肾病的早期发展。

方法和结果

通过腹腔注射一水合阿脲(200 mg/kg/d)两次并灌胃 EGCG3"Me 15 d,在小鼠中诱导糖尿病。试剂盒和 Western blot 结果显示,在糖尿病肾脏中,血清中的羰基蛋白增加;在不溶性蛋白部分,4-羟基壬烯醛修饰的蛋白质、IUP 聚集物和 p62 积累;傅里叶变换红外光谱(FT-IR)研究表明,脂质含量、反平行β-折叠结构和聚集物增加。EGCG3"Me 治疗可有效逆转这一过程,甚至比阴性对照治疗更好。

结论

EGCG3"Me 具有抗富含β-折叠的 IUP 聚集物的特性,可能代表了一种阻止糖尿病肾病和其他糖尿病并发症进展的新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68e9/3787087/836a8bc5e977/pone.0075687.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验